MedPath

Dietary Polyphenols and Lipid Oxidation

Not Applicable
Completed
Conditions
Obesity, Insulin Sensitivity, Type 2 Diabetes Mellitus
Interventions
Dietary Supplement: Comparison of different combinations of polyphenols with respect to effects on fat oxidation
Registration Number
NCT01302639
Lead Sponsor
Maastricht University Medical Center
Brief Summary

There are strong indications that (combinations of) polyphenols may be attractive candidates in the prevention of the metabolic syndrome and diabetes through modulation of pathways of fatty acid metabolism and mitochondrial function. We hypothesize that the combination of specific polyphenols, with partly distinct mechanisms of action, may have physiologically significant effects on fat oxidation through additive or synergistic effects, thereby improving body composition, insulin sensitivity and preventing type 2 diabetes. The following objective will be addressed in the current study:

(1) to test short term (3 day) effects of combinations of polyphenols (supplements of EGCG either in combination with resveratrol or with resveratrol and genistein) to affect systemic lipolysis and fat oxidation during overnight fasted conditions and after ingestion of a high fat meal in overweight subjects

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • overweight men and women (BMI≥25kg/m2- 29.9 kg/m2), aged 30-70 years, Caucasian, normal fasting glucose (< 6.1 mmol/L) and blood pressure (systolic blood pressure 100-140 mmHg, diastolic blood pressure 60-90 mmHg), weight stable in last 3 months (± 2kg). Exclusion criteria:
Exclusion Criteria
  • women lactating, pregnant or (post)menopausal, regular smokers, people with intensive fitness training, eg. athletes (≥ 3 per week ≥ 1 hour training), habitual consumption of green tea (more than 1 cup per day) or products containing green tea extract, total caffeine consumption > 300 mg/day, alcohol intake >20 g/day, any dietary vitamins or dietary supplements, diabetes mellitus (defined as FPG ≥ 7.0 mmol/l and/or 2hPG ≥ 11.1 mmol/l); serious pulmonary, cardiovascular, hepatic or renal disease : history of cardiovascular disease, all other relevant medical disorders that potentially interfere with this trial, current use of medication interfering with study intervention or interfering with study endpoints/hypotheses.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
EGCG and resveratrolComparison of different combinations of polyphenols with respect to effects on fat oxidation-
EGCG, resveratrol and genisteinComparison of different combinations of polyphenols with respect to effects on fat oxidation-
placeboComparison of different combinations of polyphenols with respect to effects on fat oxidation-
Primary Outcome Measures
NameTimeMethod
postprandial fat oxidation3 days

3 day supplementation of different combinations of polyphenols in a randomised crossover design in healthy overweight volunteers.

At the end of each supplementation period, postprandial fat oxidation is measured

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Maastricht University

🇳🇱

Maastricht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath